Alerts will be sent to your verified email
Verify Email
FGP
|
FGP
|
Sterling Internl.Ent
|
Vanta Bioscience
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
1.05 % | n/a | -19.16 % |
|
5yr average Equity Multiplier
|
1.09 | n/a | 5.0 |
|
5yr Average Asset Turnover Ratio
|
0.05 | n/a | 0.09 |
|
5yr Avg Net Profit Margin
|
61.47 % | n/a | -72.95 % |
|
Price to Book
|
3.27 | n/a | 1.34 |
|
P/E
|
0.0 | n/a | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
0.0 | n/a | 391.21 Days |
|
Inventory Days
|
0.0 | n/a | 550.05 Days |
|
Days Receivable
|
0.0 | n/a | 524.58 Days |
|
Days Payable
|
415.0 Days | n/a | 1235.82 Days |
|
5yr Average Interest Coverage Ratio
|
-1325.47 | n/a | -0.2 |
|
5yr Avg ROCE
|
-3.44 % | n/a | -3.41 % |
|
5yr Avg Operating Profit Margin
|
-329.83 % | n/a | -33.08 % |
|
5 yr average Debt to Equity
|
0.0 | n/a | 3.47 |
|
5yr CAGR Net Profit
|
n/a | n/a | n/a |
|
5yr Average Return on Assets
|
1.08 % | n/a | -3.03 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
41.45 % | n/a | 72.81 % |
|
Share Pledged by Promoters
|
0.0 | n/a | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | n/a | 2.88 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | n/a | 0.0 |
|
FGP
|
Sterling Internl.Ent
|
Vanta Bioscience
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
-
|
Product Wise Break-Up
|